Diabetes on the college campus

Pediatric Clinics of North America

Volumn 52, Issue 1, 2005, Pages 279-305

  Kamboj, Manmohan K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; AMFEBUTAMONE; AMYLIN; ANTIDIABETIC AGENT; ASPART; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIGUANIDE; CANNABIS; CARBOHYDRATE; DIURETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN; MIGLITOL; NORTRIPTYLINE; PIOGLITAZONE; PNEUMOCOCCUS VACCINE; PRAMLINTIDE; REPAGLINIDE; ROSIGLITAZONE; SIBUTRAMINE; SULFONYLUREA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLOOD GLUCOSE MONITORING; CAREER; COLLEGE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DRINKING; DRIVING ABILITY; DRUG DOSE REGIMEN; EXERCISE; GASTROINTESTINAL DISEASE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNIZATION; INCIDENCE; INDEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET TRANSPLANTATION; PREGNANCY; PREVALENCE; REVIEW; SMOKING; SOCIAL PSYCHOLOGY; SPORT;

EID: 14844300080     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.11.006     Document Type: Review

References (62)

1. American Diabetes Association Medical management of type 1 diabetes B.W. Bode Diagnosis and classification/pathogenesis 4th edition 2004 American Diabetes Association Alexandria, VA 5 18
2. American Diabetes Association. Epidemiology of type 2 diabetes and obesity in children. In: Rosenblum A.L., Silverstein J.H., editors. Type 2 diabetes in children and adolescents. Alexandria, VA: American Diabetes Association. p. 17-24
3. American Diabetes Association Diagnosis and classification of diabetes mellitus (position statement) Diabetes Care 27 Suppl 1 2004 S5 S10
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
5. American Diabetes Association Type 2 diabetes in children and adolescents (consensus statement) Diabetes Care 23 2000 381 389
6. American Diabetes Association Type 2 diabetes in children and adolescents Pediatrics 105 2000 671 680
7. American Diabetes Association Screening for diabetes (position statement) Diabetes Care 27 Suppl 1 2004 S11 S14
8. American Diabetes Association Standards of medical care in diabetes (position statement) Diabetes Care 26 Suppl 1 2004 S15 S35
9. F.R. Kaufman, and M. Halvorson The treatment and prevention of diabetic ketoacidosis in children and adolescents with type 1 diabetes Pediatr Ann 28 1999 576 582
10. American Diabetes Association Hyperglycemic crisis in diabetes (position statement) Diabetes Care 26 Suppl 1 2004 S94 S102
11. A.E. Kitabchi, G.E. Umpierrez, and M.B. Murphy Management of hyperglycemic crises in patients with diabetes mellitus [technical review] Diabetes Care 24 2001 131 153
12. American Diabetes Association Special situations B.W. Bode Medical management of type 1 diabetes 4th edition 2004 American Diabetes Association Alexandria, VA 121 160
13. American Diabetes Association Insulin administration (position statement) Diabetes Care 26 Suppl 1 2004 S111 S113
14. American Diabetes Association Multiple component insulin regimens in therapy in intensive diabetes management G.J. Klingensmith Intensive diabetes management 3rd edition 2003 American Diabetes Association Alexandria, VA
15. American Diabetes Association Insulin infusion pump therapy in intensive diabetes management G.J. Klingensmith Intensive diabetes management 3rd edition 2003 American Diabetes Association Alexandria, VA
16. M.J. Lenhard, and G.D. Reeves Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy Arch Intern Med 161 2001 2293 2300
17. J. Pickup, and H. Keen Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes Diabetes Care 25 2002 593 598
18. Bristol-Meyers Squibb Glucophage (metformin) [package insert] 1999 Bristol-Meyers Squibb New York
19. J.R. White The pharmacological reduction of blood glucose in patients with type 2 diabetes mellitus Clin Diabetes 16 1998 58 67
20. American Diabetes Association Overview of medications used to treat type 2 diabetes R.K. Campbell J.R. White Medications for the treatment of diabetes 3rd edition 2000 American Diabetes Association Alexandria, VA 23 43
21. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2003 393 403
22. J. Tuomilehto, J. Lindstrom, and J.G. Eriksson Prevention of type 2 diabetes mellitus by changes in life-style among subjects with impaired glucose tolerance N Engl J Med 244 2001 1343 1350
23. N.J. Stone Focus on lifestyle change and the metabolic syndrome Endocrinol Metab Clin N Am 33 2004 493 508
24. American Diabetes Association Nutrition principles and recommendations in diabetes (position statement) Diabetes Care 27 Suppl 2004 S36 S46
25. M.J. Franz, J.P. Bantle, and C.A. Beebe Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications [technical review] Diabetes Care 25 2002 148 198
26. American Diabetes Association Management D.B. Kelley Medical management of type 2 diabetes 1998 American Diabetes Association Alexandria, VA 27 85
27. American Diabetic Association Tests of glycemia in diabetes (position statement) Diabetes Care 26 Suppl. 1 2004 S91 S93
28. R. Schiaffini, P. Ciampalini, and A. Fierabracci The continuous glucose monitoring system (CGMS) in type I diabetic children is the way to reduce hypoglycemic risk Diabetes Metab Res Rev 18 2002 324 329
29. R.C. Eastman, H.P. Chase, and B. Buckingham Use of the GlucoWatch Biographer in children and adolescents with diabetes Pediatr Diabetes 3 2002 127 134
30. N. Sachedina, and J.C. Pickup Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type I diabetic subjects Diabet Med 20 12 2003 1012 1015
31. P.W. Speiser Continuous glucose monitoring in managing diabetes in children Diabetes Metab Res Rev 18 2002 330 331
32. D.E. Goldstein, R.R. Little, R.A. Lorenz, J.L. Malone, D. Nathan, and C.M. Peterson Tests of glycemia in diabetes [technical review] Diabetes Care 18 1995 896 909
33. D.S. Sacks, D.E. Bruns, D.E. Goldstein, N.K. Maclaren, J.M. McDonald, and M. Parrott Guidelines and recommendations for laboratory analyses in the diagnosis and management of diabetes mellitus Diabetes Care 25 2002 750 786
34. M.B. Draznin Type I diabetes and sports participation-strategies for training and competing safely Phys Sports Med 28 12 2000 49 56
35. American Diabetes Association Smoking and diabetes (position statement) Diabetes Care 27 Suppl 1 2004 S74 S75
36. American Diabetes Association Influenza and pneumococcal immunizations in diabetes (position statement) Diabetes Care 26 Suppl 1 2004 S111 S113
37. th edition 2004 American Diabetes Association Alexandria, VA
38. P.E. Cryer, S.N. Davis, and H. Shamoon Hypoglycemia in diabetes Diabetes Care 26 2003 1902 1912
39. L.M. Aiello Perspectives on diabetic retinopathy Am J Ophthalmol 136 2003 122 135
40. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
41. Diabetes Control and Complications Trial Research Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy. The Diabetes Control and Complications Trial Diabetes 44 1995 968 983
42. American Diabetes Association Diabetic retinopathy (position statement) Diabetes Care 27 Suppl 1 2004 S84 S87
43. American Diabetes Association Diabetic nephropathy (position statement) Diabetes Care 27 Suppl 1 2004 S79 S83
44. American Diabetes Association Complications B.W. Bode Medical management of type 1 diabetes 4th edition 2004 American Diabetes Association Alexandria, VA 183 233
45. H.R. Jacobson, and G.E. Striker Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease Am J Kidney Dis 25 1995 103 106
46. C.E. Mogensen, W.F. Keane, and P.H. Bennett Prevention of diabetic renal disease with special reference to microalbuminuria Lancet 346 1995 1080 1084
47. P.H. Bennett, S. Haffner, and B.L. Kasiske Screening and management of microalbuminuria in patients with diabetes mellitus Am J Kidney Dis 25 1995 107 112
48. G. Remuzzi, P. Ruggenenti, and N. Perico Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition Ann Intern Med 136 2002 604 615
49. A.I. Vinik, T.S. Park, K.B. Stansberry, and G.L. Pittenger Diabetic neuropathies Diabetologia 43 2000 957 973
50. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
51. American Diabetic Association Treatment of hypertension (position statement) Diabetes Care 27 Suppl 1 2004 S65 S67
52. American Diabetes Association Preconception care of women with diabetes (position statement) Diabetes Care 27 Suppl 1 2004 S76 S83
53. American Diabetes Association Epidemiology of type 2 diabetes and obesity in children A.L. Rosenbloom J.H. Silverstein Type 2 diabetes in children and adolescents 2003 American Diabetes Association Alexandria, VA 25 45
54. R.D. Goldney, P.J. Phillips, L.J. Fisher, and D.H. Wilson Diabetes, depression, and quality of life Diabetes Care 27 2004 1066 1070
55. E.H.B. Lin, W. Katon, and M. Von Korff Relationship of depression and diabetes self-care, medication adherence, and preventive care Diabetes Care 27 2004 2154 2160
56. P.J. Lustman, R.J. Anderson, K.E. Freedland, M. de Groot, R.M. Carney, and R.E. Clouse Depression and poor glycemic control: a meta-analytic review of the literature Diabetes Care 23 7 2000 934 942
57. American Diabetes Association Emerging therapies B.W. Bode Medical management of type I diabetes 4th edition 2004 American Diabetes Association Alexandria, VA 233 248
58. G.M. Steil, N. Blumauer, J. Leech, K. Long, A.E. Panteleon, and K. Rebrin Closed loop insulin delivery using subcutaneous (SC) glucose sensing and SC insulin delivery [abstract] Diabetes 50 Suppl 2 2001 A132
59. J.B. Buse, C. Weyer, and D.G. Maggs Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy Clin Diabetes 20 2002 137 144
60. J.J. Gagliardino, H. Del Zotto, L. Massa, L.E. Flores, and M.I. Borelli Pancreatic duodenal homeobox-1 and islet neogenesis-associated protein: a possible combined marker of activateable pancreatic cell precursors J Endocrinol 177 2 2003 249 259
61. A.M.J. Shapiro, J.R.T. Lakey, and E.A. Ryan Islet transplantation in seven patients with type 1 diabetes using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 2000 230 238
62. E.A. Ryan, J.R. Lakey, and R.V. Rajotte Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol Diabetes 50 4 2001 710 719